The injectable drug offers a twice-yearly alternative to daily pills, marking a significant step in global HIV prophylaxis efforts.

tag:reuters.com,2023:binary_RC2GA1A2WV6Q-BASEIMAGE

Revista Science a votat cea mai importantă descoperire ştiinţifică în 2024: Un medicament împotriva infectării cu HIV

Digi 24

Romania

Science magazine voted the most important scientific discovery in 2024: A drug against HIV infection

The journal Science chose the injectable drug lenacapavir as a scientific discovery in 2024. The drug, which acts as a pre-exposure prophylaxis (PrEP) against HIV, was 100% effective in a clinical trial with women in Africa, released by the pharmaceutical company Gilead Sciences in June.
Read more (12/12/2024)

A revista Science elegeu o medicamento injet�vel lenacapavir como descoberta cient�fica de 2024. A droga, que atua como uma profilaxia pr�-exposi��o (PrEP) contra HIV, teve efic�cia de 100% em um ensaio cl�nico com mulheres na �frica, divulgado pela farmac�utica Gilead Sciences em junho.
Leia mais (12/12/2024

Lenacapavir é eleita descoberta de 2024 pela Science - 12/12/2024 - Ciência

Grupo Folha

Brazil

Lenacapavir is elected 2024 discovery by Science - 12/12/2024

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.

Ad Fontes Media

All Sides

Media Bias/Fact Check

National Public Radio, Inc

Washington

District of Columbia

United States

This drug is the 'breakthrough of the year' -- and it could mean the end of the HIV epidemic

Lenacapavir is a medication that prevents HIV from entering and replicating within the human cells that the virus attacks. In a clinical trial with women in Africa, it was shown to prevent 100% of infections.

O lenacapavir é um medicamento que impede o VIH de entrar e de se replicar dentro das células humanas que o vírus ataca. Num ensaio clínico com mulheres em África, mostrou prevenir 100% das infecções.

Novo medicamento “é o mais próximo que alguma vez estivemos de uma vacina contra o VIH”

Publico

Sonae

Portugal

New drug “is the closest we've ever been to an HIV vaccine”

Every year, the important scientific journal "Science" recognizes a research breakthrough of the year. This year, a drug was selected that represents a major advance in protection against HIV. This is the third award in the field of HIV research since 1996.

Jährlich würdigt das wichtige Fachjournal „Science“ einen Forschungsdurchbruch des Jahres. In diesem Jahr wurde ein Medikament ausgewählt, das einen großen Fortschritt beim Schutz vor HIV bedeutet. Es ist bereits die dritte Auszeichnung im Bereich der HIV-Forschung seit 1996.

Renommiertes Fachmagazin „Science“: HIV-Schutz Lenacapavir ist Durchbruch des Jahres

rnd.de

Germany

Renowned scientific journal “Science”: HIV protection Lenacapavir is breakthrough of the year

Among the research highlights listed below, this year's list also includes Austro-references.

Unter nachgereihten Forschungs-Highlights finden sich in der diesjährigen Liste auch Austro-Bezüge.

HIV-Spritze ist für Fachblatt "Science" der "Durchbruch des Jahres"

Kurier

Funke Mediengruppe

HIV injection is the "breakthrough of the year" for the journal "Science"

90. Millions of people around the world were dying from a new and then unknown infection called HIV/AIDS, which attacks white blood cells, weakening the immune system critically. The epidemic, spread through unprotected sexual contact, does not distinguish from classes: Freddy Mercury, Rock Hudson or Anthony Perkins were some of the famous characters who died after getting infected. In Spain, at the beginning of that decade, it was the first cau…

Años 90. Millones de personas morían en todo el mundo por una nueva y entonces desconocida infección bautizada como VIH/sida, que ataca a los glóbulos blancos, debilitando el sistema inmunitario de forma crítica. La epidemia, que se contagia a través del contacto sexual sin protección, no distingue de clases: Freddy Mercury, Rock Hudson o Anthony Perkins fueron algunos de los personajes célebres que murieron tras contagiarse. En España, a princi…

El fármaco que protege del VIH con dos inyecciones al año, mayor avance del 2024 para 'Science'

Grupo Vocento

Spain

The drug that protects against HIV with two injections a year, the highest advance of 2024 for 'Science'

An injection every six months can protect against HIV infection. The drug Lenacapavir is the most important research breakthrough of the year according to the specialist magazine "Science". The development of the drug makes "a big difference".

Eine Spritze alle sechs Monate kann vor einer HIV-Infektion schützen. Das Medikament Lenacapavir ist für das Fachmagazin "Science" der wichtigste Forschungsdurchbruch des Jahres. Die Entwicklung des Mittels mache "einen großen Unterschied".

Schützt vor HIV-Infektion: Lenacapavir ist "Durchbruch des Jahres"

n-tv.de

Bertelsmann Stiftung

Protects against HIV infection: Lenacapavir is "Breakthrough of the Year"

The development of the drug Lenacapavir, which prevents HIV infection, is the most important scientific breakthrough of 2024, according to a jury in the journal Science, naming it “Discovery of the Year”.

Dezvoltarea medicamentului Lenacapavir, care previne infectarea cu virusul HIV, este cea mai importantă descoperire ştiinţifică din 2024, a stabilit un juriu din cadrul revistei Science, care desemnează „Descoperirea anului”.

Digi Communications

The six-month prophylaxis facilitates treatment and reduces stigma. Other award-winning projects have participation from Austria

Die sechsmonatige Prophylaxe erleichtert die Behandlung und reduziert das Stigma. Weitere ausgezeichnete Projekte haben eine Beteiligung aus Österreich

der Standard AT

Oscar Bronner

Vienna

Austria

While the National Assembly must approve the list of its various study groups, the one on HIV-AIDS would not be renewed. An unjustifiable suppression that would mean the abandonment of the fight against an epidemic that is as devastating as ever, denounce elected officials Anne Souyris, Arthur Delaporte and Jean-Luc Romero-Michel.

Alors que l’Assemblée nationale doit approuver la liste de ses différents groupes d’études, celui sur le VIH-sida ne serait pas renouvelé. Une suppression injustifiable qui signerait l’abandon d’une lutte contre une épidémie toujours aussi dévastatrice, dénoncent les élus Anne Souyris, Arthur Delaporte et Jean-Luc Romero-Michel.

Lenacapavir Named 'Breakthrough of the Year' for Advancing HIV Prevention

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics